Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Prostate Cancer Recurrent × Clear all

Phase

Phase NA 5 Phase 3 2 Phase 2 2 Phase 4 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 235 Neoplasms 173 Prostatic Neoplasms 104 Polycystic Ovary Syndrome 103 Colorectal Neoplasms 96 Carcinoma, Hepatocellular 91 Carcinoma, Non-Small-Cell Lung 80 Lung Neoplasms 60 Stomach Neoplasms 55 Precursor Cell Lymphoblastic Leukemia-Lymphoma 55 Pain 53 Neoplasm Metastasis 47 Multiple Myeloma 44 Pancreatic Neoplasms 43 Keratosis, Actinic 41 Pain, Postoperative 39 Leukemia, Myeloid, Acute 38 Head and Neck Neoplasms 36 Leiomyoma 35 Liver Neoplasms 34 Recurrence 33 Lymphoma 33 Uterine Cervical Neoplasms 32 Colonic Neoplasms 32 Papillomavirus Infections 31 Brain Neoplasms 31 Infertility 29 Lymphoma, Follicular 28 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 28 Leukemia 28

Interventions

acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01512472 2019-09-23

FIT

Canadian Urology Research Consortium

Phase 4 Terminated

Prostate Cancer Recurrent

Data powered by HemOnc (CC BY 4.0) Colophon ⚡